This vulnerability is evidenced by the differing interaction kinetics of Hsp90 with small molecules between normal and transformed cells that lack the MYC gene-reinforcing influence and cancer cells with the MYC reinforcement [6]. The gene discussed is HSP90AB1; the disease is cancer.